Novo Ventures
Europe, Hovedstaden, Denmark, Bagsværd
Description
Novo A/S is a Danish private limited liability company wholly owned by the Novo Nordisk Foundation, and the holding company of the Novo
Investor Profile
Novo Ventures has made 76 investments, with 0 in the past 12 months and 36% as lead.
Stage Focus
- Series B (38%)
- Series A (25%)
- Series C (11%)
- Series D (9%)
- Series Unknown (8%)
- Seed (4%)
- Post Ipo Equity (3%)
- Series E (1%)
- Private Equity (1%)
Country Focus
- United States (66%)
- United Kingdom (14%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Switzerland (7%)
- France (5%)
- Canada (3%)
- Denmark (3%)
- The Netherlands (1%)
- China (1%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Pharmaceutical
- Medical
- Biopharma
- Medical Device
- Life Science
- Wellness
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
